Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS
Authors:
- Frida DuellFDFrida Duell
- Björn EvertssonBEBjörn Evertsson
- Faiez Al NimerFNFaiez Al Nimer
- Åsa SandinÅSÅsa Sandin
- Daniel OlssonDODaniel Olsson
- Tomas OlssonTOTomas Olsson
- Mohsen KhademiMKMohsen Khademi
- Max Albert HietalaMHMax Albert Hietala
- Fredrik PiehlFPFredrik Piehl
- Magnus HanssonMHMagnus Hansson
Open Access
- 1 July 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 7 (4)
Abstract
Objective To determine what kappa free light chain (KFLC) metric has the highest capacity to separate healthy patients from patients with MS, we evaluated the sensitivity, specificity, and the overall diagnostic accuracy of 4 different KFLC metrics. To assess the usefulness of KFLC in the diagnostics of MS, we compared the different KFLC metrics with oligoclonal bands (OCBs), the current gold standard biochemical method to demonstrate intrathecal antibody production. Methods CSF and plasma were collected from patients with confirmed or suspected MS, other neurological diseases, as well as symptomatic and healthy controls between May 2017 and May 2018 (n = 335) at the Department of Neurology, Karolinska University Hospital, as part of routine diagnostic workup. KFLC analysis and isoelectric focusing for the detection of oligoclonal bands (OCB) were determined and correlated with diagnosis. Receiver operating characteristic (ROC) curve analysis was used to determine accuracy. Results OCBs yielded a sensitivity of 87% and a specificity of 100%. All KFLC metrics showed a high sensitivity (89%–95%) and specificity (95%–100%). Using the optimal cutoff according to the Youden Index resulted for the KFLC intrathecal fraction in a cutoff of −0.41 with a sensitivity of 95% and a specificity of 97% and for CSF KFLC/CSF albumin with a cutoff of 1.93 × 10−3 with a sensitivity of 94% and specificity of 100%. Conclusion All evaluated KFLC metrics have excellent accuracy, and both KFLC intrathecal fraction and CSF KFLC/CSF albumin are at least as good as OCB in separating patients with MS from a control group. Classification of evidence This study provides Class III evidence that CSF KFLC accurately distinguishes patients with MS from healthy controls.Keywords
This publication has 25 references indexed in Scilit:
- Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter studyMultiple Sclerosis Journal, 2015
- High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosisJournal of Neuroimmunology, 2014
- Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CISPLOS ONE, 2014
- Determination of kFLC and K Index in cerebrospinal fluid: A valid alternative to assessintrathecal immunoglobulin synthesisJournal of Neuroimmunology, 2013
- Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosisMultiple Sclerosis Journal, 2013
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobankingNeurology, 2009
- The diagnosis of multiple sclerosis and the clinical subtypesAnnals of Indian Academy of Neurology, 2009
- Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosisJournal of Neurology, 2008
- Intrathecal IgM synthesis is a prognostic factor in multiple sclerosisAnnals of Neurology, 2002